Reiko Sakaguchi, MSc

  • 1Article
  • 5.4KReads
  • 2024Active
  • 4Collaborators
  • 1Citations

About

Reiko Sakaguchi, MSc is affiliated with Department of Clinical Research, Drug Development Division, Sumitomo Pharma Co., Ltd., Tokyo, Japan. Reiko Sakaguchi has contributed 1 peer-reviewed article published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders in 2024. Their work focuses on Schizophrenia/Schizoaffective Disorders.

Publications

JCP
Effect of Lurasidone on Social Functioning
Original Research

Effect of Lurasidone on Social Functioning

January 31, 2024

Impaired social functioning in schizophrenia affects personal recovery. This analysis looked at the effects of lurasidone on social functioning in schizophrenia during a double-blind, placebo-controlled study and subsequent open-label...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe